canakinumab monoclonal antibody drug molecule. targets interleukin-1 beta and is used in the treatment of a number of auto-

antibody autoinflammatory beta biological biosimilar biotech biotechnology canakinumab caps caspase cryopyrinassociated disease drug fever il1b immunoglobulin immunology infusion injection inn interleukin mab monoclonal nomenclature peptide periodic protein rare syndromes